Moderna Inc., US60770K1079

Moderna stock pre-market at EUR 170.25: plus 0.94 percent

Published on 10/05/2026 at 07:57 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Moderna stock was at EUR 170.25 pre-market, up plus 0.94 percent versus the EUR 168.67 Lang & Schwarz prior close on October 2, 2026. Juan Andres became COO on October 5.

Isometrische 3D-Grafik zeigt Pharma-Wertschöpfungskette von Labor bis Krankenhaus
Moderna Inc. (US60770K1034) illustriert die isometrische Wertschöpfungskette der Biotech-Branche von Forschung bis zur finalen Auslieferung, Illustration mit AI erstellt.

Moderna stock was at EUR 170.25 in pre-market trading on October 5, 2026, at 7:56 a.m. CEST, according to Lang & Schwarz. The price was plus 0.94 percent versus the Lang & Schwarz prior close of EUR 168.67 on October 2, 2026.

Pre-market price

Lang & Schwarz showed a price of EUR 170.25 for Moderna at 7:56 a.m. CEST on October 5, 2026, compared with the prior close of EUR 168.67. The further course from the Xetra open at 9:00 a.m. CET/CEST is shown by the continuously updated real-time quote of Moderna stock.

Moderna appoints chief operating officer

In a September 30, 2026, release published by Nasdaq, Moderna said Juan Andres would return to the company as chief operating officer effective October 5, 2026. He will report to Chief Executive Officer Stéphane Bancel, serve on Moderna's Executive Committee and lead the manufacturing organization.

The company also said Chief Technical Operations and Quality Officer Jerh Collins had decided to retire. Moderna linked the newly created COO role to the increasing scale and diversification of the company and said it was preparing for the potential launch and scale-up of intismeran autogene, which is jointly developed with Merck.

Disclaimer...

en | US60770K1079 | MODERNA INC. | boerse | 70229841 | bgmi